Literature DB >> 2903386

Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children.

H Campbell1, P Byass, I M Forgie, K P O'Neill, N Lloyd-Evans, B M Greenwood.   

Abstract

134 Gambian children under 5 years of age with severe pneumonia (as defined by the World Health Organisation classification of acute respiratory infections) were given either oral co-trimoxazole for 5 days, or a single intramuscular dose of fortified procaine penicillin and 5 days of oral ampicillin. At 2 weeks, there was no significant difference in outcome between the two groups. Co-trimoxazole is much less expensive than ampicillin or procaine penicillin, requires only twice-daily administration, and can be given by health-care staff with little training. The results support the use of co-trimoxazole as the antibiotic of first choice in outpatient management of young children with pneumonia in developing countries.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903386     DOI: 10.1016/s0140-6736(88)90244-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Oral antibiotics versus parenteral antibiotics for severe pneumonia in children.

Authors:  M X Rojas; C Granados
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Randomized trial of sulfamethoxazole + trimethoprim versus procaine penicillin for the outpatient treatment of childhood pneumonia in Zimbabwe.

Authors:  D J Keeley; F K Nkrumah; C Kapuyanyika
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 3.  Antimicrobial Therapy in Community-Acquired Pneumonia in Children.

Authors:  Samriti Gupta; Rakesh Lodha; S K Kabra
Journal:  Curr Infect Dis Rep       Date:  2018-09-20       Impact factor: 3.725

4.  A clinical and economic study of community-acquired pneumonia between single versus combination therapy.

Authors:  Mohamed Azmi Ahmad Hasali; Mohamed Izham Mohamed Ibrahim; Syed Azhar Syed Sulaiman; Zhari Ahmad; Jameela Banu Ahmad Hasali
Journal:  Pharm World Sci       Date:  2005-06

5.  Randomised, controlled trial of effectiveness of ampicillin in mild acute respiratory infections in Indonesian children.

Authors:  B Sutrisna; R R Frerichs; A L Reingold
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

Review 6.  Short-course therapy for community-acquired pneumonia in paediatric patients.

Authors:  Shamim Qazi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997.

Authors:  S K Saha; N Rikitomi; M Ruhulamin; H Masaki; M Hanif; M Islam; K Watanabe; K Ahmed; K Matsumoto; R B Sack; T Nagatake
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 8.  Antibiotics for community-acquired pneumonia in children.

Authors:  Rakesh Lodha; Sushil K Kabra; Ravindra M Pandey
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

Review 9.  Management of community-acquired pneumonia in children.

Authors:  Krishne Chetty; Anne H Thomson
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 10.  Pneumonia and other respiratory infections.

Authors:  Sarath C Ranganathan; Samantha Sonnappa
Journal:  Pediatr Clin North Am       Date:  2009-02       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.